Come up with a name for your new list and we'll add to it:
Chromis Therapeutics raised a round of funding on February 26, 2016. Investors include
Torrey Pines Invesment.
Chromis Therapeutics is a biopharmaceutical company, focused on the development of novel curative treatments for chronic HBV infection. Chromis uses new proprietary drug design and discovery platform …